Numinus Wellness Inc. (OTCQX: NUMIF) has successfully orchestrated a financing strategy to secure $6 million by entering into a definitive agreement for...
Toronto, Ontario–(Newsfile Corp. – February 1, 2024) – PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) (“PharmaDrug” or the “Company“), is...
The financing drew support from a cohort that includes MAPS. The post Investors rally behind Numinus Wellness in a $6M bought deal appeared first on Green...
Numinus Wellness (TSX: NUMI) has received a major vote of confidence, announcing last night that it will be conducting a The post Numinus Sees Integrated...
Rohan is a seasoned product leader with 17 years of experience across a range of startups BharatPe Group, India’s leading name in the fintech ecosystem,...
The firm will now able to conduct research trials in the United States. The post Filament Health’s psychedelic drug candidate gains FDA nod appeared...
VANCOUVER, BC, Jan. 31, 2024 /CNW/ – Filament Health Corp. (OTCQB: FLHLF) (Cboe CA: FH) (FSE: 7QS) (“Filament” or the “Company“), a clinical‐stage...
SAN FRANCISCO – Jaguar Health, Inc. (NASDAQ: JAGX) today announced that a preclinical study in mice initiated in Brazil by Magdalena Biosciences,...
TORONTO, Jan. 30, 2024 (GLOBE NEWSWIRE) — Huxley Health Inc. (“Huxley” or the “Company”) is pleased to provide you with a comprehensive corporate...
MindBio Therapeutics Corp. announced it is nearing the completion of its Phase 2a clinical trial using MB22001 in patients with Major Depressive Disorder....